IP Library Granted Patent US 9,333,258
Granted Patent B2
US 9,333,258 · App. 14/379,488 · Granted May 10, 2016

Fine spatiotemporal control of fat removal using NIR light

Inventors: Adah Almutairi (La Jolla, CA); Khalid Almutairi (La Jolla, CA)
Assignees: The Regents of the University of California; eLux Medical, Inc.
A61K41/0052A61B18/04A61B18/20A61K33/24A61M1/008A61N5/062A61B2018/00464A61M2202/08A61N2005/067A61N2005/0626A61N2005/0659
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,258
App. No.
14/379,488
Granted
May 10, 2016
Kind
B2
Abstract

A system and method are provided for minimally-invasive removal of fat from a target area by injecting the area with a solution of photo-absorbing nanoparticles and irradiating the injected area with a beam of near infrared (NIR) light. The NIR emission wavelength excites the nanoparticles to melt and liquefy fat within the target area so that the liquefied fat can be aspirated from the target area. The nanoparticles may be gold nanorods having aspect ratios selected to produce surface plasmon resonance when irradiated with NIR light around 800 nm.

Claims (24)

1. A system for minimally-invasive fat removal from a subcutaneous target area, comprising:

a solution of photo-absorbing nanoparticles having an aspect ratio in the range of 1:3 to 1:5;

an injector for subcutaneously injecting the solution directly into the target area;

a near infrared light source configured for delivering a beam of light within an emission wavelength range of 600 to 950 nm to the target area;

at least one beam adjusting optical element for controlling focus and beam size to select the target area;

a system controller for providing control signals to the near infrared light source, wherein the control signals comprise selection of an emission wavelength within the emission wavelength range, an emission intensity and an exposure duration, and wherein the system controller is configured to select the emission wavelength to excite the nanoparticles to a temperature to melt and liquefy fat within the target area and the emission intensity and exposure duration to modulate heating to minimize damage to tissue adjacent the fat; and

an extractor configured for subcutaneous insertion for extracting liquefied fat from the target area.

2. The system of claim 1 , wherein the nanoparticles are biocompatible.

3. The system of claim 1 , wherein photo-absorption in the nanoparticles is mediated by surface plasmon resonance.

4. The system of claim 1 , wherein the nanoparticles absorb in the near infrared range (700-900 nm).

5. The system of claim 1 , wherein the nanoparticles are gold nanorods.

6. The system of claim 5 , wherein the gold nanorods have an axial diameter of approximately 10 nm and a longitudinal diameter in the range of 9 to 50 nm.

7. The system of claim 5 , wherein the gold nanorods are suspended in water at a concentration of 3×10 11 or 3×10 12 GNR/mL.

8. The system of claim 1 , wherein the near infrared light source is a NIR laser having at least one of tunable power and tunable wavelength.

9. The system of claim 8 , wherein the NIR laser emits light within the wavelength range of 700 to 900 nm.

10. The system of claim 8 , wherein the NIR laser emits light having a wavelength of approximately 800 nm.

11. The system of claim 8 , wherein the beam size is within the range of lmm to 5 mm diameter.

12. The system of claim 8 , wherein the tunable power is within the range of 0.6 to 15 W.

13. The system of claim 8 , wherein the exposure duration is within the range of 30-45 seconds.

14. A photothermal method of in vivo fat removal comprising the melting and liquefying of fat using the system of claim 1 .

15. A method of inducing skin tightening around regions from which adipose tissue has been removed using the system of claim 1 .

16. A system for in vivo photothermal removal of subcutaneous fat in a target area, the system comprising: photo-absorbing nanoparticles having an aspect ratio of 1:3 to 1:5 suspended in a solution; a near infrared light source configured for delivering a light beam to the target area, the near infrared light source comprising a system controller for generating control signals controlling delivery parameters of the light beam, wherein the control signals comprise selection of an emission wavelength within an emission wavelength range of 700 to 900 nm, an emission intensity and an exposure duration, and wherein the system controller is configured to select the emission wavelength to excite the nanoparticles to a temperature to melt and liquefy fat within the target area and the emission intensity and exposure duration to modulate heating to minimize damage to tissue adjacent the fat; a first syringe adapted for directly subcutaneously injecting the nanoparticle solution into the target area; and a second syringe or cannula adapted for aspirating melted and liquefied fat from the target area after exposure of the target area to NIR light energy.

17. The system of claim 16 , wherein the photo-absorbing nanoparticles are gold nanorods having an axial diameter of approximately 10 nm and a longitudinal diameter in the range of 9 to 50 nm.

18. The system of claim 16 , wherein the system controller is configured to select an emission wavelength of 800 nm.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2014
From: ALMUTAIRI, KHALID, DR.
To: ELUX MEDICAL, INC.
Reel/Frame 034285/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2014
From: ALMUTAIRI, ADAH
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 033975/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2014
From: ALMUTAIRI, KHALID
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; ELUX MEDICAL, INC.
Reel/Frame 033975/0764 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2014
From: ALMUTAIRI, KHALID
To: ELUX MEDICAL, INC.
Reel/Frame 033975/0781 →
Continuity (2)
Provisional Application 61644328 · May 8, 2012
Related Publication 20150018812A1 · Jan 15, 2015